FibroBiologics secures European patent for fibroblast delivery of cancer treatments
FBLG•FibroBiologics received a European patent covering engineered fibroblasts that deliver oncolytic viruses to tumors, with protection extending to modified cells used alongside existing cancer therapies.
1. European patent granted
FibroBiologics received a European patent covering fibroblasts engineered to deliver oncolytic viruses to tumors. The patent also protects modified cells for cancer treatment alongside existing therapies.
